Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer
2019 · Scientific Reports · 35 citations
https://doi.org/10.1038/s41598-019-54804-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
25
Papers
289
Citations
8
h-index
8
i10-index
Ayano Iwazaki is an academic researcher from Setsunan University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Chemotherapy-induced cardiotoxicity and mitigation & Pharmacy and Medical Practices. The author has an h-index of 8, co-authored 22 publications.
Click to start Chat